Doctor of Medicine (May 2003)
University of Colorado Health Sciences Center
Denver, CO
Bachelor of Arts (1997), Economics, cum laude
Rice University
Houston, TX
Radiation Oncology Resident
University of Colorado Health Sciences Center
Aurora, CO
Transitional Year Intern
Presbyterian/St. Luke's Hospital
HealthSouth
Denver, CO
Pending
Pass
Pass
99th percentile
99th percentile
88th percentile
Score 233, 96th percentile (2006)
Score 242, 98th percentile (2002)
Score 250, 99th percentile (2001)
Chief Resident, Radiation Oncology
University of Colorado Health Sciences Center
Lead Resident, Radiation Oncology
University of Colorado Health Sciences Center
Commencement Class Speaker, School of Medicine
University of Colorado Health Sciences Center
Junior Alpha Omega Alpha (AOA)
Buckley Scholarship for Outstanding Student in
Basic Sciences, UCHSC
Merit Scholarship, Rice University
National Merit Scholar
American Society of Therapeutic Radiology and Oncology
American Society of Clinical Oncology
American Brachytherapy Society
American Medical Association
Colorado Medical Society
Alpha Omega Alpha
1. McCammon RJ, Furuya CE, Raben D, Song JI, Kane M, Gaspar LE, Chen C. The influence offluorine-18-flourodeoxyglucose positron emission tomography (FDGPET) on the clinical management of patients with head and neck cancer. American Society for Therapeutic Radiology and Oncology (ASTRO), Philadelphia, PA, November 5-9, 2006. Poster Presentation
2. Raben D, McCammon RJ, Newell S, Kavanagh B. Acute toxicity assessment of a single institution series of prostate cancer patients treated with pelvic intensity modulated radiation therapy with synchronous integrated boost to the prostate or prostate bed. American Society for Therapeutic Radiology and Oncology (ASTRO), Philadelphia, PA, November 5-9, 2006. Poster Viewing
3. McCammon RJ. Rocky Mountain Thoracic Oncology Symposium, Beaver Creek, CO, October 2004. Case Presentation
1. Ballenger's Otorhinolaryngology Head and Neck Surgery, RC. Decker Publishers, 17th edition (in-press). McCammon RJ, Chen C, Suntha M, Raben D. Chemoradiation for Head and Neck Cancer: Current Approaches and Future Directions.
2. McCammon RJ, FUruya CE, Raben D, Song JI, Kane M, Gaspar LE, Chen C. The influence of fluorine-18- flourodeoxyg1ucose positron emission tomography (FDGPET) on the clinical management of patients with head and neck cancer. Int J Radiat Oncol BioI Phys 2006;66(3):S184-185.
3. Raben D, McCammon RJ, Newell S, Newman F, Kavanagh R Acute toxicity assessment of a single institution series of prostate cancer patients treated with pelvic intensity modulated radiation therapy with synchronous integrated boost to the prostate or prostate bed. Int J Radiat Oncol Biol Phys 2006;66(3):S364.
4. Web MD (www.webmd.com). McCammon RJ. Gynecologic Malignancies, 2005.
5. UpToDate (www.uptodate.com). McCammon RJ. Spinal Cord and Peripheral Nerve Toxicity from Radiation, 2005.
1. McCammon RJ, Zeng C, Kavanagh R Improved local control associated with stereotactic body radiation therapy (SBRT) dose escalation indicates a doseresponse relationship. [Accepted for Poster Presentation ASTRa 2007]
2. McCammon RJ, Finlayson T, Rabinovitch R. Survival Impact of Post-mastectomy Radiotherapy in T3NOInvasive Ductal or Lobular Carcinoma of the Breast: A Surveillance, Epidemiology, and End-Results (SEER) Database Analysis. [Accepted for poster presentation at ASCa Breast Symposium 2007]
3. Ballonoff A, McCammon RJ, Rusthoven K, Kavanagh R Improved survival with neoadjuvant radiotherapy in esophageal cancer: A Surveillance, Epidemiology, and End-Results (SEER) Database Analysis. [Accepted for oral presentation at ASTRa 2007]
4. Schwer A, McCammon RJ, Kavanagh B, et al. Magnetic resonance imaging (MRI) T1 and T2 volumetric changes and their implications after hypofractionated stereotactic radiotherapy (HSRT) in patients with recurrent malignant gliomas. [Accepted for poster presentation at ASTRa 2007]
5. Ballonoff A, Rusthoven K, Schwer A, Kavanagh B, McCammon RJ, and Rabinovitch R. Improved survival in patients with stage I or II Diffuse Large B-Cell Lymphoma Treated with Radiotherapy: A Surveillance, Epidemiology, and End-Results (SEER) Analysis. [Accepted for oral presentation at ASTRa 2007]
